Appointments and advancements for Aug. 7, 2020

New hires and promotions in the biopharma industry, including: Fibrogen, Okyo, Xortx.

Earnings for Aug. 7, 2020

Quarterly snapshots from biopharma companies with marketed products, including: Adamas, Amag, Beigene, Clovis, Coherus, Exelixis, Dynavax, Fibrogen, GW, Ocular, Puma.

Financings for Aug. 7, 2020

Biopharmas raising money in public or private financings, including: Arya, Biohaven, Checkmate, FSD, Freeline, Horizon.

In the clinic for Aug. 7, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Cstone, Everest, Ligand, Oncolys, Oncopeptides, Roche, Satsuma.

Other news to note for Aug. 7, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Cancer Targeted Technology, Conifer, Editas, Ensysce, Ev, Eversana, Gilead, Immvira, Lodo, Moderna, Mucokinetica, Novavax, Nura, Pfizer, Shanghai Pharmaceuticals, Takeda, Yulong, Zosano.

Regulatory actions for Aug. 7, 2020

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Biogen, Canbridge, Cytodyn, Eisai, Intellia, Kazia, PTC, Roche, Viiv.

No Comments